head_banner1

products

  • Roxithromycin Dispersible Tablets

    Roxithromycin Dispersible Tabulettae

    Regulatory Status: Chinese medicamentis licentia

    Robur: 75mg

    Manufacturer: Hebei Ai'er Haitai

  • Ketorolac tromethamine

    Ketorolac tromethamine

    Nomen Iaponica:

    Pharmacopoeia: ChP/USP

    CAS Number: 74103-07-4

    CDMF No.: Y20210000317

    Formulae hypotheticae: C19H24N2O6

    Pondus hypotheticum: 376.400 g/mol

    Indicationes clinicae: Brevis terminus (usque ad 5 dies in adultis), administratio doloris modice gravis acuti, qui analgesiam requirit in gradu opioide.

  • Telmisartan capsules

    Capsulae Telmisartan

    Regulatory Status: Chinese medicamentis licentia

    Robur: 40mg

    Manufacturer: Hebei Ai'er Haitai

  • Thioctic Acid Trometamol

    Acidum Thioctic Trometamol

    Synonym: Acidum Lipoicum tromethamine

    Nomen Iaponica:

    Pharmacopoeia: /

    CAS Number: 62-46-4

    CDMF No.: Y2000000812

    Formulae hypotheticae: C8H14O2S2·C4H11NO3

    Pondus hypotheticum: 327.460 g/mol

    Acta indicia: Vasculares accentus in aegris cum diabete

  • Bromhexine Hydrochloride for Injection

    Bromhexine hydrochloride pro Iniectio

    Regulatory Status: Chinese medicamentis licentia

    Robur: 4mg

    Manufacturer: Hebei Zhitong Biotech

  • Maxacalcitol

    Maxacalcitol

    Nomen Iaponica:

    Pharmacopoeia: JP

    CAS Number: 103909-75-7

    CDMF No.: Ut sit relatus

    Formulae hypotheticae: C26H42O4

    Pondus hypotheticum: 418.618 g/mol

    Indicationes clinicae: hyperparathyroidismi secundae, Psoriasis

  • Paricalcitol

    Paricalcitolum

    Nomen Iaponica:

    Pharmacopoeia: USP

    CAS Number: 131918-61-1

    CDMF No.: Ut sit relatus

    Formulae hypotheticae: C27H44O3

    Pondus hypotheticum: 416.646 g/mol

    Indicationes clinicae: hyperparathyroidism secundae

  • Cobamamide for Injection

    Cobamamide pro Iniectio

    Regulatory Status: Chinese medicamentis licentia

    Robur: 0.5mg/1.0mg/1.5mg

    Manufacturer: Hebei Zhitong Biotech

  • Regadenoson

    Regadenoson

    Nomen Iaponica:

    Pharmacopoeia: /

    CAS Number: 313348-27-5

    USDMF No.: 036679

    CDMF No.: Y2000000551

    Formulae hypotheticae: C15H18N8O5

    Pondus hypotheticum: 390.350 g/mol

    Indicationes clinicae: Accentus pharmacologicus agentis indicatur propter perfusionem radionuclidis myocardialis imaginandi (MPI) in aegris non valentibus adaequatam exercitium accentus subire.

  • Levofloxacin Hydrochloride Injection

    Levofloxacin hydrochloride Iniectio

    Regulatory Status: Chinese medicamentis licentia

    Strengt: 10ml: 0.5g

    Manufacturer: Hebei Zhitong Biotech

  • Tacalcitol monohydrate

    Tacalcitolum monohydratorum

    Nomen Iaponica:

    Pharmacopoeia: BP/EP/JP

    CAS Number: 93129-94-3

    CDMF No.: Y20180001179

    Formulae hypotheticae: C27H44O3•H2O

    Pondus hypotheticum: 434.661 g/mol

    Indicationes clinicae: Psoriasis Vulgaris

  • Vinpocetine for Injection

    Vinpocetine pro Iniectio

    Regulatory Status: Chinese medicamentis licentia

    Robur: 5mg

    Manufacturer: Hebei Zhitong Biotech